Thalia Therapeutics is a drug reformulation company.
Thalia Therapeutics has raised $3.6M in total funding. The most recent round was Post-IPO Secondary. The last funding was announced in June 2026.
Thalia Therapeutics's investors include Innovate UK.
Thalia Therapeutics is headquartered in Chellaston, United Kingdom.
Thalia Therapeutics is a drug reformulation company.
Thalia Therapeutics is at the Post-IPO Secondary stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thalia Therapeutics — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/thalia-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Thalia Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/thalia-therapeutics
{{cite web |title=Thalia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thalia-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated